Canada to receive significant doses from Covax fund meant to ensure access for poor countries; Chile and New Zealand to also receive above-average Covax doses
- UK passes 10m Covid vaccination milestone
- GSK and CureVac sign deal to develop multi-variant vaccine
- Canada takes Covax vaccines despite side deals
- See all our coronavirus coverage
1.16am GMT
More on Canada’s vaccine supply now, from the Guardian’s Michael Safi and Leyland Cecco:
Global health authorities have criticised countries for making private deals that they say push up vaccine prices and represent a form of “double-dipping” – taking supplies from Covax while at the same time signing private deals that make it harder for the facility to secure doses that would be shared equitably.
Related: Canada takes Covax vaccines despite side deals
12.55am GMT
Volunteers are being sought for a world-first trial to establish the efficacy of giving people a first dose of one vaccine and a second dose of a different vaccine.
The trial, which is being run by Oxford University and is funded by the government’s vaccine taskforce, has been described by ministers as “hugely important”.
Related: Oxford trial to test efficacy of mix of Covid vaccines for individuals
Continue reading…Canada to receive significant doses from Covax fund meant to ensure access for poor countries; Chile and New Zealand to also receive above-average Covax doses UK passes 10m Covid vaccination milestoneGSK and CureVac sign deal to develop multi-variant vaccineCanada takes Covax vaccines despite side dealsSee all our coronavirus coverage 1.16am GMTMore on Canada’s vaccine supply now, from the Guardian’s Michael Safi and Leyland Cecco:Global health authorities have criticised countries for making private deals that they say push up vaccine prices and represent a form of “double-dipping” – taking supplies from Covax while at the same time signing private deals that make it harder for the facility to secure doses that would be shared equitably. Related: Canada takes Covax vaccines despite side deals 12.55am GMTVolunteers are being sought for a world-first trial to establish the efficacy of giving people a first dose of one vaccine and a second dose of a different vaccine.The trial, which is being run by Oxford University and is funded by the government’s vaccine taskforce, has been described by ministers as “hugely important”. Related: Oxford trial to test efficacy of mix of Covid vaccines for individuals Continue reading…